Axon Enterprise Inc (NASDAQ:AXON) shares are rebounding on Wednesday. Goldman Sachs released an analyst note that maintained its rating. Here’s what you should know.

Axon's rebound follows a sharp risk-off tape on Tuesday, when the Nasdaq fell 1.16% and the S&P 500 shed 0.73% after durable goods orders declined 1.4% in February. Traders are watching whether Wednesday's strength can stick after risk-off volatility across the market pressured high-multiple names.

Notable Developments

Goldman Sachs analyst Michael Ng maintained a Buy rating on Axon and lowered its price target to $625 from $720.

Additionally, the broader market is surging today, with the Nasdaq (QQQ) up 2.93% and the S&P 500 (SPY) up 2.37%. Industrials (XLI) are leading sector gains at 3.73%, and Axon's rally is happening in a session where market breadth is strongly positive.

Axon Technical Analysis

At $398.15, Axon is trading 14.8% below its 20-day simple moving average (SMA), the stock's average price over the last 20 sessions, which suggests the short-term trend is still pointed down. It's also 24.8% below its 100-day SMA, indicating the intermediate trend remains under pressure even after today's bounce.

The relative strength index (RSI), a momentum gauge, is 24.16, which is consistent with oversold conditions after heavy selling pressure. That oversold reading can coincide with sharp rebounds, but it also reflects how stretched the recent downtrend has become.

  • Key Support: $396.50 — a near-term line where buyers have recently shown up.

Axon’s Background

Axon is building a public safety operating system by integrating hardware devices with cloud software. Its lineup spans cloud-hosted digital evidence management, TASER energy devices, body and in-car cameras, drones and robotic security, plus training tools.

The business is split into Software and Services and Connected Devices, with most revenue coming from Connected Devices (TASER, cameras, drones and accessories/warranties). That mix matters for the stock's reaction to analyst notes because investors often weigh hardware demand and subscription-like software expansion differently when thinking about longer-term growth and valuation.

Analyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $725.71. Recent analyst moves include:

  • Goldman Sachs: Buy (Lowers Target to $625.00) (April 8)
  • UBS: Neutral (Lowers Target to $570.00) (Feb. 25)
  • Barclays: Overweight (Lowers Target to $682.00) (Feb. 25)

Benzinga Edge Rankings: The Benzinga Edge scorecard for Axon highlights its strengths and weaknesses compared to the broader market.

  • Momentum: Bearish (Score: 3.37) — The stock's trend signals remain very weak versus the broader tape.
  • Value: Bearish (Score: 1.07) — The market is pricing in a lot of optimism relative to fundamentals.
  • Growth: Neutral (Score: 64.1) — Growth factors screen as solid, but not strong enough to offset weak momentum.

The Verdict: Axon’s Benzinga Edge signal reveals a growth-leaning story that's currently being weighed down by very weak momentum and a stretched valuation profile. For longer-term investors, the setup reads like "good business, tough chart," where improving trend signals would matter as much as growth execution.

AXON Price Action: Axon shares were up 5.99% at $395.19 at the time of publication on Wednesday, according to Benzinga Pro.

Image: Shutterstock